Introduction: The Case for Prioritizing Diabetic Rights in Public Policy

Diabetes has rapidly emerged as one of the most pressing global health challenges of the 21st century. According to the World Health Organization, approximately 422 million people worldwide live with diabetes, and the number continues to climb across every region and age group. Despite this staggering prevalence, the rights and needs of individuals with diabetes are frequently marginalized or completely overlooked when governments and international bodies develop public health policies. This systemic oversight leads to inequities in access to care, financial toxicity from unaffordable medications, and social discrimination that undermines the ability of people with diabetes to manage their condition effectively. Advocating for diabetic rights within the framework of public health policy is not merely a matter of medical necessity—it is a fundamental human rights imperative. This article examines the critical importance of recognizing diabetic rights, the persistent barriers faced by the diabetes community, and concrete strategies for embedding those rights into policy development processes.

The Foundational Importance of Recognizing Diabetic Rights

Recognition of diabetic rights means affirming that every person with diabetes has the right to the highest attainable standard of health, as enshrined in international human rights instruments such as the International Covenant on Economic, Social and Cultural Rights. This includes access to essential medicines like insulin and glucose monitoring supplies, affordable and appropriate healthcare services, protection from discrimination, and meaningful participation in decisions that affect their lives. Without explicit consideration of diabetic rights, policies risk perpetuating inequalities that disproportionately affect low-income populations, racial and ethnic minorities, and rural communities. For example, insulin pricing crises in many countries force patients to ration doses—a life-threatening practice that would be unthinkable for other chronic conditions. Recognizing diabetic rights legally and practically would compel governments to regulate drug prices, mandate insurance coverage, and ensure that public health programs are inclusive and responsive.

Persistent Challenges Facing People with Diabetes

People with diabetes encounter a complex web of obstacles that extend far beyond clinical management. These barriers are structural, financial, social, and educational. Understanding them is essential for effective advocacy.

Financial Toxicity of Diabetes Care

The cost of insulin has skyrocketed in many parts of the world, particularly in the United States where prices have increased by more than 50% over the past decade. A 2023 study published in the Journal of the American Medical Association found that nearly one in four American diabetics report rationing insulin due to cost. This financial burden also applies to test strips, continuous glucose monitors, pump supplies, and diabetes-related medical appointments. In low- and middle-income countries, access to even basic insulin is inconsistent. The International Diabetes Federation Atlas estimates that over 60 million people with type 2 diabetes do not have access to the medicines they need. Without a policy framework that prioritizes affordability, the financial toll of diabetes will continue to drive poor health outcomes and premature deaths.

Limited Access to Specialized Healthcare

Many regions, especially rural and underserved areas, lack endocrinologists, diabetes educators, and dietitians. Even where specialists exist, long wait times and high out-of-pocket costs create barriers. Public health policies that do not invest in a diabetes-competent workforce or in telemedicine services leave patients to navigate complex self-management alone. For example, a person with type 1 diabetes may need regular consultations to adjust insulin doses, but without accessible specialists, they rely on primary care providers who may have limited training in diabetes management—increasing the risk of complications such as retinopathy, neuropathy, and cardiovascular disease.

Stigma and Discrimination in Everyday Environments

People with diabetes frequently face discrimination in employment, education, and public life. Employers may refuse reasonable accommodations such as breaks for blood glucose checks or snack consumption. Schools have been known to exclude children with diabetes from activities or fail to train staff to assist with emergencies like hypoglycemia. Public perception often wrongly associates diabetes with personal failing, especially for type 2, leading to blame and shame. This stigma can deter individuals from disclosing their condition or seeking timely care. While many countries have anti-discrimination laws, they are inconsistently enforced and rarely explicitly include chronic conditions like diabetes. Amending public policies to mandate reasonable accommodations and to prosecute discriminatory practices is a core advocacy priority.

Low Health Literacy and Awareness

Understanding how to manage diabetes—counting carbohydrates, adjusting insulin, recognizing symptoms of complications—is a demanding skill set. Yet public health education campaigns are often generic and do not reach vulnerable populations. Many people first learn they have diabetes during a medical emergency. Without sustained, culturally appropriate education, patients may adopt harmful practices or delay seeking help. Policy-level investment in community health education, school-based diabetes literacy, and media campaigns can dramatically improve outcomes. However, such programs are frequently underfunded or absent from national health strategies.

Strategic Approaches for Embedding Diabetic Rights in Public Health Policy

Advocacy for diabetic rights must move beyond awareness-raising to produce concrete policy change. A multi-pronged strategy that involves coalition building, evidence-based arguments, and sustained engagement with decision-makers is required.

Building Strong Coalitions Across Sectors

No single organization can drive policy change alone. Effective advocacy requires alliances between diabetes patient groups, healthcare professional associations, human rights organizations, pharmaceutical cost watchdogs, and public health researchers. These coalitions can amplify messages, pool resources, and present a unified front to policymakers. For example, the T1International movement has successfully brought together activists from over 30 countries to demand affordable insulin and transparent pricing. Coalition members should agree on a shared set of policy demands—such as a cap on insulin copays, inclusion of diabetes devices in national formularies, and anti-discrimination protections—and then coordinate lobbying efforts at local, national, and global levels.

Using Data to Drive Policy Arguments

Policy makers respond to compelling evidence. Advocates must equip themselves with data on the economic burden of diabetes complications (e.g., the cost of amputations, dialysis, and hospitalizations) versus the cost of preventive care and medication access. For instance, the American Diabetes Association published an economic analysis showing that every dollar invested in diabetes self-management education saves up to three dollars in healthcare costs. Presenting such data in briefs, testimonies, and media op-eds makes the case that diabetic rights policies are not just ethical but also fiscally responsible. Additionally, collecting disaggregated data on how diabetes affects different populations—by race, income, geography—can reveal disparities that demand targeted policy interventions.

Engaging People with Diabetes in Policy Design

The slogan “Nothing about us without us” applies powerfully to diabetic rights. Too often, health policies are devised by experts who have never experienced the daily realities of diabetes. Including people with diabetes as equal partners on advisory committees, review panels, and legislative hearings ensures that policies are grounded in lived experience. For example, when the United Kingdom’s National Institute for Health and Care Excellence (NICE) updates diabetes guidelines, it includes patient representatives who help shape recommendations on technology access and support services. Policymakers should adopt similar participatory models in all stages of policy development—from agenda setting to evaluation.

Lobbying for Affordable Medications and Technologies

Price regulation and market reforms are critical to achieving diabetic rights. Advocates can push for policies such as:

  • Price transparency laws that require manufacturers to publicly justify costs
  • Cap on out-of-pocket expenses for insulin, similar to the $35 copay cap in the U.S. Medicare program
  • Bulk purchasing and generic licensing to reduce drug costs, as demonstrated by the World Health Organization’s prequalification program
  • Waiver of tariffs and taxes on essential diabetes supplies in low-income countries

Such measures require coordinated advocacy featuring testimonies from patients harmed by high costs, economic analyses, and pressure on legislators. Advocacy groups like the Insulin for All campaign have used petitions and social media mobilization to force hearings on insulin pricing in state and national legislatures.

Incorporating Diabetes Rights into Anti-Discrimination Laws

Legal protection is a cornerstone of diabetic rights. Advocates should work to explicitly include diabetes and other chronic conditions in disability rights legislation wherever possible. This includes ensuring that the workplace accommodations required under laws such as the Americans with Disabilities Act are consistently applied to diabetes-related needs. Furthermore, school districts should adopt policies that guarantee the right to carry glucose supplies, test blood sugar, and receive assistance from trained staff. In many countries, law reform is the most sustainable way to protect diabetic rights, as it creates binding obligations for both public and private entities.

Leveraging Global Platforms and Frameworks

International organizations such as the World Health Organization, the United Nations, and the International Diabetes Federation offer platforms for elevating diabetic rights as a global policy issue. Advocates can participate in World Health Assembly resolutions, submit shadow reports on human rights compliance, and push for diabetes to be included in Universal Health Coverage packages. The United Nations Political Declaration on Noncommunicable Diseases provides a framework for requiring governments to develop national action plans that address diabetes prevention, treatment, and rights. By using these channels, national advocacy groups can gain legitimacy and pressure their own governments to fulfill international commitments.

The Crucial Roles of Education and Community Engagement

Policy change is more likely to be implemented and sustained when it is supported by an informed and mobilized public. Education and community engagement create the demand for diabetic rights and ensure that policies are culturally competent.

Health Literacy as a Policy Priority

Governments should invest in nationwide campaigns that teach basic diabetes management skills, the importance of regular screenings, and how to navigate healthcare systems. In particular, programs targeting high-risk populations—such as indigenous communities, migrant workers, and low-income urban dwellers—should be co-designed with community members to respect cultural beliefs and languages. Health literacy also includes teaching people how to advocate for themselves: knowing what accommodations they can request at work, how to appeal insurance denials, and where to report discrimination. Embedding health literacy in national curricula and public health branding transforms it from an optional extra to a systemic right.

Community Health Workers as Policy Bridging Agents

Community health workers (CHWs) who are themselves living with diabetes or have strong ties to affected communities can serve as powerful allies for policy implementation. They can deliver peer education, help patients navigate bureaucracy, and collect grassroots data that reveals policy gaps. For example, in the Navajo Nation, CHWs have been instrumental in reducing diabetes complications by connecting patients to dialysis services and food assistance programs. Advocacy efforts should push for sustainable funding for CHW programs within public health systems, as well as for their inclusion in policy advisory roles.

Combating Stigma Through Public Awareness Campaigns

Stigma reduction requires consistent, well-designed campaigns that separate the disease from blame. Policies should fund media initiatives that feature diverse people with diabetes living full lives and emphasize that diabetes is a biological condition, not a moral failing. Schools should implement anti-stigma education as part of health classes, and workplace wellness programs should train managers to avoid discriminatory language. When public policy explicitly aims to destigmatize a condition, it sends a powerful signal that diabetic rights are a societal priority.

Successful Examples of Diabetic Rights Advocacy

Looking at real-world successes can inspire and guide advocacy efforts.

Mexico’s Universal Coverage for Diabetes Medicines

In 2020, Mexico expanded its universal health coverage scheme to include free insulin and diabetes medications for all citizens, removing copays that had been a major barrier. This policy change resulted from years of lobbying by patient groups who documented cases of people dying because they could not afford insulin. By aligning with the government’s commitment to universal health coverage, advocates successfully framed diabetic rights as a core element of social justice.

India’s National Diabetes and Cardiovascular Disease Control Program

India launched a national program that provides subsidized screening, medications, and counselling for diabetes through primary health centres. While challenges remain, the program’s explicit focus on including diabetes in primary care—combined with aggressive awareness campaigns—has led to early detection in millions of previously undiagnosed individuals. Advocacy groups played a key role in demanding that public funds be allocated for diabetes rather than relying solely on out-of-pocket payments.

The U.S. Insulin Copay Cap Movement

State-level caps on insulin copays (starting with Colorado in 2019) and the federal $35 cap for Medicare enrollees enacted in the Inflation Reduction Act of 2022 illustrate sustained advocacy success. These victories were driven by a coalition of patient activists, non-profits, and legislators who shared emotional testimonies and demanded regulation. While price transparency remains an ongoing fight, the caps have provided immediate financial relief to millions, demonstrating that persistent advocacy can overcome powerful industry opposition.

Conclusion: A Call to Institutionalize Diabetic Rights

The journey toward equitable public health policies for people with diabetes is far from over. Despite growing awareness and some notable wins, the vast majority of countries still lack comprehensive legal frameworks that protect diabetic rights. As diabetes prevalence continues to rise, especially among younger populations, the moral and economic cost of inaction will only grow. Advocates, healthcare providers, and policymakers must work together to ensure that diabetic rights are not an afterthought but a central pillar of public health systems. This means capping drug prices, investing in education, enforcing anti-discrimination laws, and, most importantly, including people with diabetes as equal partners in every policy discussion. Only by embedding these rights into the fabric of public policy can we create a world where no one dies or suffers unnecessarily from a condition that is fundamentally manageable. The time to act is now—and the blueprint lies in the collective voice of the diabetes community, demanding the recognition and respect it deserves.